知名中药企业遭重罚!大批药品价格“腰斩”,64个品种集采将至,石药、兴齐眼药亮了

米内网
26 Apr

看点view本周,国家新政放宽医药市场准入,中纪委发文剑指医药腐败,多名医院“一把手”落马;药品市场迎变局,64个品种集采将至,大批药品价格“腰斩”,77个新药进院可期;企业大新闻,兴齐眼药大手笔现金分红,知名药企被终止上市,石药多款1类新药临床报喜......医药行业一周大事件,精彩不容错过!米内一周TOP榜药企动态海思科独家品种大涨45%,22款1类新药发力昔日100亿净利润药企首亏,13家...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10